Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R O Day

Showing results (161-170 of 188) with videos related to

Pageof 19
Sort By:
Drugs|September 1, 1994
New uses for allopurinolR O Day, D J Birkett, M Hicks, et al.
British Journal of Clinical Pharmacology|April 1, 1996
Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjectsS Graham, R O Day, H Wong, et al.
Clinical Pharmacology and Therapeutics|May 1, 1988
Stereoselective disposition of ibuprofen enantiomers in synovial fluidR O Day, K M Williams, G G Graham, et al.
Internal Medicine Journal|April 21, 2016
A time and motion study of junior doctor work patterns on the weekend: a potential contributor to the weekend effect?L C Richardson, E C Lehnbom, M T Baysari, et al.
Agents and Actions. Supplements|January 1, 1977
Salicylates in rheumatoid arthritis: pharmacokinetics and analgesic responseG G Graham, G D Champion, R O Day, et al.
The Medical Journal of Australia|March 16, 1992
An attempt to influence hypnotic and sedative drug useD L Carey, R O Day, D R Cairns, et al.
British Journal of Rheumatology|February 1, 1988
The oncogenicity of chlorambucil in rheumatoid arthritisH Patapanian, S Graham, P N Sambrook, et al.
Internal Medicine Journal|February 4, 2015
Understanding and improving the use of allopurinol in a teaching hospitalR C Hmar, D R W Kannangara, S N Ramasamy, et al.
Applied Clinical Informatics|January 24, 2014
Audit and feedback of antibiotic use: utilising electronic prescription dataM T Baysari, K Oliver, B Egan, et al.
European Journal of Clinical Pharmacology|June 26, 2018
Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM)S S Kumar, H McManus, T Radovich, et al.
Pageof 19

Showing results (161-170 of 188) with videos related to

Sort By:
Pageof 19
Drugs|September 1, 1994
New uses for allopurinolR O Day, D J Birkett, M Hicks, et al.
British Journal of Clinical Pharmacology|April 1, 1996
Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjectsS Graham, R O Day, H Wong, et al.
Clinical Pharmacology and Therapeutics|May 1, 1988
Stereoselective disposition of ibuprofen enantiomers in synovial fluidR O Day, K M Williams, G G Graham, et al.
Internal Medicine Journal|April 21, 2016
A time and motion study of junior doctor work patterns on the weekend: a potential contributor to the weekend effect?L C Richardson, E C Lehnbom, M T Baysari, et al.
Agents and Actions. Supplements|January 1, 1977
Salicylates in rheumatoid arthritis: pharmacokinetics and analgesic responseG G Graham, G D Champion, R O Day, et al.
The Medical Journal of Australia|March 16, 1992
An attempt to influence hypnotic and sedative drug useD L Carey, R O Day, D R Cairns, et al.
British Journal of Rheumatology|February 1, 1988
The oncogenicity of chlorambucil in rheumatoid arthritisH Patapanian, S Graham, P N Sambrook, et al.
Internal Medicine Journal|February 4, 2015
Understanding and improving the use of allopurinol in a teaching hospitalR C Hmar, D R W Kannangara, S N Ramasamy, et al.
Applied Clinical Informatics|January 24, 2014
Audit and feedback of antibiotic use: utilising electronic prescription dataM T Baysari, K Oliver, B Egan, et al.
European Journal of Clinical Pharmacology|June 26, 2018
Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM)S S Kumar, H McManus, T Radovich, et al.
Pageof 19